"Australia has some of the basic building blocks, including an “abundance of world class universities and an abundance of world class intellectual property. It also has an abundance of CROs (contract research organisations) to develop late stage assets. What we don’t have is the piece in the middle which is the preclinical experience to develop these early stage assets and the investors to fund it.”Proto Axiom is set to announce its first major investment with a second expected early next year....Read the articlehttps://www.theaustralian.com.au/business/backing-biotechs-with-usstyle-entrepreneurialism/news-story/4b5b76f83fcd2e1fa2ed00d5d84f0bd8...About Proto Axiom 

Marc Hamilton, Professor of Health and Human Performance at the University of Houston, has discovered such an approach for optimal

Scientists at CSIRO (Australia's Government Science & Industrial Research Organisation) are developing a machine learning tool which provides an early warning to medical professionals of a patient’s deteriorating condition.   The study, published in Nature: Scientific Reports, showed the early warning deterioration alerts can be set to monitor patients two to eight hours before they are triggered by current clinical criteria.  CSIRO's Dr Dr Sankalp Khanna says, 'Until now there hasn’t been a way to harness all the data to predict patient health. This new tool has the potential to transform the day-to-day functioning of health systems'.     

At an estimated $6.2 billion, Israel’s healthcare technology industry is a global leader in innovations across various medical fields. With over 1,400 digital health start-ups to date, Israel ranks 5th in the world according to the World Index for Healthcare Innovation. Investors have taken notice of such success. According to a recent survey conducted by McKinsey & Company group of Israeli venture capital funds and investment bodies, 60 percent of investors said they expect to invest more in digital health in 2022, with only 4 percent expecting to invest less than in 2021. See more about Peregrine Ventures: https://israeltrade.org.au/2022/09/19/investing-in-the-future-of-medicine/

Collectively rare diseases are very common when you add them all up because there are many thousands of them and 80% of those rare diseases have a genetic basis. A solution works in a similar way to the Covid vaccine made by AstraZeneca. It uses a harmless virus to take a genetic message into the body. And that vector system is used to then ferry that genetic payload intravenously to the liver where it takes up residence, and hopefully, after a single injection, corrects that person's genetic abnormality for the rest of their life. https://www.abc.net.au/radionational/programs/healthreport/gene-therapy-rare-diseases/101405506

Just visited the Priceline Bondi Junction Pharmacy that has a machine to give you a free health check in 4 mins. You can check body mass and blood pressure to see any warning signs. Results are shown on the screen and you can sign up to an app afterwards to keep track of them. It was a good experience and a good reason to visit a Priceline Pharmacy.